These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12591657)
1. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Bhartia B; Ward J; Guthrie JA; Robinson PJ AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657 [TBL] [Abstract][Full Text] [Related]
2. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035 [TBL] [Abstract][Full Text] [Related]
3. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. Hanna RF; Kased N; Kwan SW; Gamst AC; Santosa AC; Hassanein T; Sirlin CB AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242 [TBL] [Abstract][Full Text] [Related]
5. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119 [TBL] [Abstract][Full Text] [Related]
6. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media]. Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882 [TBL] [Abstract][Full Text] [Related]
7. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Krinsky GA; Lee VS; Theise ND; Weinreb JC; Rofsky NM; Diflo T; Teperman LW Radiology; 2001 May; 219(2):445-54. PubMed ID: 11323471 [TBL] [Abstract][Full Text] [Related]
9. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [TBL] [Abstract][Full Text] [Related]
10. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Chung J; Yu JS; Kim DJ; Chung JJ; Kim JH; Kim KW Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation. Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337 [TBL] [Abstract][Full Text] [Related]
12. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000 [TBL] [Abstract][Full Text] [Related]
15. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease. Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308 [TBL] [Abstract][Full Text] [Related]
16. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. Krinsky GA; Israel G AJR Am J Roentgenol; 2003 Apr; 180(4):1023-7. PubMed ID: 12646448 [TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents. Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenoma: MR imaging features with pathologic correlation. Chung KY; Mayo-Smith WW; Saini S; Rahmouni A; Golli M; Mathieu D AJR Am J Roentgenol; 1995 Aug; 165(2):303-8. PubMed ID: 7618545 [TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings. Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Kato H; Nishibori H; Yokoyama R; Hoshi H; Moriyama N AJR Am J Roentgenol; 2005 Mar; 184(3):832-41. PubMed ID: 15728605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]